Canada Unveils New Initiatives to Strengthen Environmental Protection
On October 5, 2024, the Government of Canada released three significant documents to implement the 2023 amendments to the Canadian Environmental Protection Act (CEPA). These documents included:
- Draft Implementation Framework for the Right to a Healthy Environment
- Proposed Plan of Priorities
- Proposed Watch List Approach
The Proposed Plan of Priorities outlined substances to be prioritized for assessment of toxicity or potential toxicity. It encompassed 14 specific substances and 18 chemical groups, including fluoropolymers, organic flame retardants, and 6PPD. Additionally, a new Watch List was introduced, featuring substances not currently classified as toxic but potentially concerning if exposure conditions change.
By June 2025 at the latest, Canada will publish a final Plan of Priorities that specifies:
- The substances to which priority should be given in assessing whether they are toxic or capable of becoming toxic.
- Activities or initiatives related to assessing, controlling, or otherwise managing the risks to the environment or human health posed by substances (particularly those of high risk).
- Activities or initiatives to promote the development and timely incorporation of scientifically justified alternative methods and strategies in the testing and assessment of substances to replace, reduce, or refine the use of vertebrate animals.
Companies operating in Canada should monitor substances on both the Priority and Watch Lists and prepare for potential future regulations. The government sought public input on these proposals until December 4, 2024, providing an opportunity for stakeholders to participate in the consultation process.
While no immediate action is required, these initiatives signal Canada's strengthened approach to chemical management. Companies should stay informed about these developments and prepare for possible regulatory changes in the future.
Stay informed. Get the latest regulatory updates, compliance insights, and CDX news delivered to your inbox.
Subscribe to our Newsletter